Benefit of statins in daily practice? A six-year retrospective observational study.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacological Research

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.phrs.2009.06.009PMID 19573601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accounting for Noncompliance in Pharmacoeconomic Evaluations

  2012cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994–2003

  2007cited by this paper
• Are lipid-lowering guidelines evidence-based?

  2007cited by this paper
• Impact of adherence to statins on coronary artery disease in primary prevention.

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy.

  2005cited by this paper
• Medication adherence trends with statins

  2005cited by this paper
• Cardiovascular Morbidity Associated with Nonadherence to Statin Therapy

  2005cited by this paper
• The analysis by Manuel and colleagues creates controversy with headlines, not data

  2005cited by this paper
• Impact of concurrent medication use on statin adherence and refill persistence.

  2004cited by this paper
• Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study;

  2004cited by this paper
• Drug treatment of hyperlipidemia in women.

  2004cited by this paper
• Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.

  2004cited by this paper
• Long term persistence with statin treatment in daily medical practice

  2004cited by this paper
• Predicting “real world” effectiveness by integrating adherence with pharmacodynamic modeling

  2003cited by this paper
• Statin compliance in the Umbrian population

  2003cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial

  2003cited by this paper
• Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

  2002cited by this paper
• Magnetic resonance imaging of left atrial thrombus

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

  2000cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience.

  1999cited by this paper
• MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

  1999cited by this paper
• Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

  1999cited by this paper
• Cholesterol reduction yields clinical benefit: impact of statin trials.

  1998cited by this paper
• The West of Scotland Coronary Prevention Study: a trial of cholesterol reduction in Scottish men.

  1995cited by this paper
• Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

  1995cited by this paper
• Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

  1995cited by this paper
• Scandinavian simvastatin study (4S)

  1994cited by this paper
• Ischaemic heart disease and cholesterol. Effective diets are unpalatable.

  1994cited by this paper
• Scandinavian simvastatin study (4S)

  1994cited by this paper
• Ischaemic heart disease and cholesterol There's more to heart disease than cholesterol

  1994cited by this paper

• Cost-utility analysis of Coronary Artery Calcium screening to guide statin prescription among intermediate-risk patients in Thailand

  2025cites this paper
• Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study

  2015cites this paper
• Association Between Persistence with Statin Therapy and Reduction in Low‐Density Lipoprotein Cholesterol Level: Analysis of Real‐Life Data from Community Settings

  2014cites this paper
• Do Randomized Clinical Trials Tell the Whole Story? Statins as a Case in Point

  2013cites this paper
• Using Stress Testing to Guide Primary Prevention of Coronary Heart Disease Among Intermediate-Risk Patients: A Cost-Effectiveness Analysis

  2012cites this paper
• Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study

  2011cites this paper